Thinkin Tech
Wearable ultrasound guidance devices for aesthetic practitioners performing dermal filler injections
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-02
About Thinkin Tech
Thinkin Tech develops SibUS-In®, a finger-worn ultrasound device that provides real-time anatomical visualization during injections. Its compact design lets practitioners use both hands while adapting the probe to facial contours.
The product is aimed at aesthetic practitioners, including dermatologists and plastic surgeons, for guided injections and related procedures. Thinkin Tech is based in Paris and was founded in 2023.
Product: SibUS-In® is a wearable finger-worn ultrasound device for real-time guidance during aesthetic injections.
Jobs at Thinkin Tech
Leadership
- Benjamin Ascher · FOUNDERSource: company website
More health & medtech companies
Tilak Healthcare
Remote monitoring app for ophthalmologists and patients with chronic retinal conditionsNew on EvolcTildev
Digital patient-care reporting and emergency-response coordination software for healthcare and emergency services organizationsNew on EvolcToda Pharma
French manufacturer of rapid diagnostic tests for healthcare professionals and institutionsNew on EvolcTrixell
Digital X-ray detectors for medical imaging equipment manufacturers and healthcare providersNew on EvolcUromems
Develops smart implantable medical devices for people with stress urinary incontinenceNew on EvolcVal Solutions
SaaS platform uEgar for French occupational health services (SPST), employers and employeesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- SquarespaceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.